Hyaluronic Acid Viscosupplementation and Osteoarthritis: Current Uses and Future Directions

被引:127
作者
Strauss, Eric J. [1 ]
Hart, Jennifer A. [2 ]
Miller, Mark D. [2 ]
Altman, Roy D. [3 ]
Rosen, Jeffrey E. [1 ]
机构
[1] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10003 USA
[2] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA USA
[3] Univ Calif Los Angeles, Div Rheumatol & Immunol, Los Angeles, CA USA
关键词
hyaluronic acid; viscosupplementation; osteoarthritis; knee; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTRAARTICULAR SODIUM HYALURONATE; G-F; 20; PYROPHOSPHATE DIHYDRATE ARTHRITIS; HYLAN G-F-20 SYNVISC(R); DOUBLE-BLIND; IRRIGATING SOLUTIONS; CLINICAL-TRIAL; INJECTION; KNEE;
D O I
10.1177/0363546508326984
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Intra-articular hyaluronic acid viscosupplementation is gaining popularity as a treatment option in the nonoperative management of patients with osteoarthritis. Recent clinical studies have demonstrated that the anti-inflammatory, anabolic, and chondroprotective actions of hyaluronic acid reduce pain and improve patient function. With evidence mounting in support of the efficacy of this treatment modality for patients with osteoarthritis, its potential use in additional patient populations and for other pathologies affecting the knee is being investigated. The current article reviews the use of intra-articular hyaluronic acid viscosupplementation in the management of knee osteoarthritis and presents the potential for expanding its indications for other joints and alternative patient subpopulations. Additionally, future directions for the use of hyaluronic acid and areas of active research are discussed.
引用
收藏
页码:1636 / 1644
页数:9
相关论文
共 90 条
[1]  
ADAMS ME, 1991, J RHEUMATOL, V18, P428
[2]   The role of viscosupplenentation with hylan G-F 20 (Synvisc(R)) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone [J].
Adams, ME ;
Atkinson, MH ;
Lussier, AJ ;
Schulz, JI ;
Siminovitch, KA ;
Wade, JP ;
Zummer, M .
OSTEOARTHRITIS AND CARTILAGE, 1995, 3 (04) :213-225
[3]   Acute pseudogout following intra-articular injection of high molecular weight hyaluronic acid [J].
Ali, Y ;
Weinstein, M ;
Jokl, P .
AMERICAN JOURNAL OF MEDICINE, 1999, 107 (06) :641-642
[4]  
Allen E, 2000, J RHEUMATOL, V27, P1572
[5]  
Altman RD, 2005, ARTHRITIS RHEUM-US, V52, pS461
[6]  
Altman RD, 1998, J RHEUMATOL, V25, P2203
[7]   Intra-articular sodium hyaluronate in osteoarthritis of the knee [J].
Altman, RD .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 30 (02) :11-18
[8]  
ALTMAN RD, 2006, OSTEOARTHRITIS CA SB, V14, pS170
[9]   Long-term effect of sodium hyaluronate (Hyalgan®) on osteoarthritis progression in a rabbit model [J].
Amiel, D ;
Toyoguchi, T ;
Kobayashi, K ;
Bowden, K ;
Amiel, ME ;
Healey, RM .
OSTEOARTHRITIS AND CARTILAGE, 2003, 11 (09) :636-643
[10]   Diagnosis and treatment of chronic painful shoulder: Review of nonsurgical interventions [J].
Andrews, JR .
ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2005, 21 (03) :333-347